Sangamo BioSciences | Zahlungsmittel Und Äquivalente

Name: Sangamo BioSciences | Zahlungsmittel Und Äquivalente
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

Preview

	Cash And Equivalent		Datum
Alnylam Pharmaceuticals ALNY:US	$ 575.56M	41.48M	2022-06
Amgen AMGN:US	$ 5203M	1325M	2022-06
Avrobio Inc AVRO:US	$ 132.41M	29.25M	2022-06
Bayer BAYN:GR	€ 3412M	2373M	2022-06
Biocryst Pharmaceuticals BCRX:US	$ 417.48M	21.98M	2022-06
Biogen BIIB:US	$ 2646.6M	897.3M	2022-06
Biomarin Pharmaceutical BMRN:US	$ 619.8M	14.36M	2022-06
Bluebird Bio BLUE:US	$ 81.5M	24.76M	2022-06
Gilead Sciences GILD:US	$ 7000M	2704M	2022-06
GlaxoSmithKline GSK:LN	646500M	450200M	2022-06
Intercept Pharmaceuticals ICPT:US	$ 58.02M	9.7M	2022-06
IONIS PHARMACEUT IONS:US	$ 521.92M	20.6M	2022-06
Karyopharm Therapeutics KPTI:US	$ 82.25M	71.01M	2022-06
Novartis NOVN:VX	SF 3625M	10227M	2022-06
Omeros OMER:US	$ 14.14M	5.17M	2022-06
Regulus Therapeutics RGLS:US	$ 35.12M	18.78M	2022-06
Sangamo Biosciences SGMO:US	$ 117.7M	2.55M	2022-06
Sarepta Therapeutics SRPT:US	$ 868.56M	365.31M	2022-06
Ultragenyx Pharmaceutical RARE:US	$ 159.87M	5.88M	2022-06
Vertex Pharmaceuticals VRTX:US	$ 8702.2M	1102.1M	2022-06
Ziopharm Oncology ZIOP:US	$ 60.01M	8.24M	2022-06

Sangamo BioSciences Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.